Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1965 1
1967 1
1969 1
1970 2
1972 3
1973 1
1974 1
1975 4
1976 3
1977 4
1979 3
1980 1
1981 3
1982 3
1983 4
1984 3
1985 3
1986 4
1987 10
1988 6
1989 3
1990 3
1991 5
1992 7
1993 7
1994 14
1995 19
1996 10
1997 13
1998 22
1999 17
2000 19
2001 17
2002 26
2003 26
2004 27
2005 30
2006 41
2007 33
2008 39
2009 52
2010 50
2011 63
2012 57
2013 46
2014 60
2015 72
2016 60
2017 73
2018 68
2019 81
2020 305
2021 385
2022 273
2023 171
2024 68

Text availability

Article attribute

Article type

Publication date

Search Results

2,014 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypogonadotropic hypogonadism 18 with or without anosmia"
Page 1
Delayed Puberty.
Mohanraj S, Prasad HK. Mohanraj S, et al. Indian J Pediatr. 2023 Jun;90(6):590-597. doi: 10.1007/s12098-023-04577-x. Epub 2023 May 2. Indian J Pediatr. 2023. PMID: 37127825 Review.
Delayed puberty is diagnosed in the absence of thelarche by 13 y or menarche by 15 y in girls and absence of testicular enlargement by 14 y in boys. Delayed puberty can be due to hypogonadotrophic hypogonadism, hypergonadotrophic hypogonadism or eugonadotrophic eugo …
Delayed puberty is diagnosed in the absence of thelarche by 13 y or menarche by 15 y in girls and absence of testicular enlargement by 14 y …
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C; Parkinson's Progression Markers Initiative. Siderowf A, et al. Lancet Neurol. 2023 May;22(5):407-417. doi: 10.1016/S1474-4422(23)00109-6. Lancet Neurol. 2023. PMID: 37059509 Free PMC article.
Among prodromal and at-risk groups, 44 (86%) of 51 of participants with RBD or hyposmia had positive alpha-synuclein SAA (16 of 18 with hyposmia, and 28 of 33 with RBD). 25 (8%) of 310 non-manifesting carriers (14 of 159 [9%] LRRK2 and 11 of 151 [7%] GBA) were positive. .. …
Among prodromal and at-risk groups, 44 (86%) of 51 of participants with RBD or hyposmia had positive alpha-synuclein SAA (16 of 18 wi …
48,XXYY, 48,XXXY and 49,XXXXY syndromes: not just variants of Klinefelter syndrome.
Tartaglia N, Ayari N, Howell S, D'Epagnier C, Zeitler P. Tartaglia N, et al. Acta Paediatr. 2011 Jun;100(6):851-60. doi: 10.1111/j.1651-2227.2011.02235.x. Epub 2011 Apr 8. Acta Paediatr. 2011. PMID: 21342258 Free PMC article. Review.
Sex chromosome tetrasomy and pentasomy conditions occur in 1:18,000-1:100,000 male births. While often compared with 47,XXY/Klinefelter syndrome because of shared features including tall stature and hypergonadotropic hypogonadism, 48,XXYY, 48,XXXY and 49,XXXXY syndr …
Sex chromosome tetrasomy and pentasomy conditions occur in 1:18,000-1:100,000 male births. While often compared with 47,XXY/Klinefelt …
Current clinical management of constitutional delay of growth and puberty.
Gaudino R, De Filippo G, Bozzola E, Gasparri M, Bozzola M, Villani A, Radetti G. Gaudino R, et al. Ital J Pediatr. 2022 Mar 24;48(1):45. doi: 10.1186/s13052-022-01242-5. Ital J Pediatr. 2022. PMID: 35331309 Free PMC article. Review.
In details, pediatricians often cannot differentiate CDGP from permanent hypogonadotropic hypogonadism (PHH), with definitive diagnosis of PHH awaiting lack of puberty by age 18 yr. ...Patients with transient delay in hypothalamic-pituitary-gonadal axis matur …
In details, pediatricians often cannot differentiate CDGP from permanent hypogonadotropic hypogonadism (PHH), with definitive …
Anosmia, mild cognitive impairment, and biomarkers of brain aging in older adults.
Dong Y, Li Y, Liu K, Han X, Liu R, Ren Y, Cong L, Zhang Q, Hou T, Song L, Tang S, Shi L, Luo Y, Kalpouzos G, Laukka EJ, Winblad B, Wang Y, Du Y, Qiu C. Dong Y, et al. Alzheimers Dement. 2023 Feb;19(2):589-601. doi: 10.1002/alz.12777. Epub 2022 Sep 15. Alzheimers Dement. 2023. PMID: 36341691
Olfactory impairment was significantly associated with increased likelihoods of MCI, amnestic MCI, and non-amnestic MCI. In the subsamples, anosmia was significantly associated with higher plasma total tau and NfL concentrations, smaller hippocampal and entorhinal cortex v …
Olfactory impairment was significantly associated with increased likelihoods of MCI, amnestic MCI, and non-amnestic MCI. In the subsamples, …
Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease.
Schrag A, Bohlken J, Dammertz L, Teipel S, Hermann W, Akmatov MK, Bätzing J, Holstiege J. Schrag A, et al. JAMA Neurol. 2023 Feb 1;80(2):161-171. doi: 10.1001/jamaneurol.2022.3902. JAMA Neurol. 2023. PMID: 36342675 Free PMC article.
Consistent with previous reports, risk factors and prodromal features associated with PD included traumatic brain injury, odds ratio (OR), 1.62; 95% CI, 1.36-1.92; alcohol misuse, OR, 1.32; 95% CI, 1.21-1.44; hypertension, OR, 1.29; 95% CI, 1.26-1.31; anosmia, OR, 2.16; 95 …
Consistent with previous reports, risk factors and prodromal features associated with PD included traumatic brain injury, odds ratio (OR), 1 …
Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease.
Luskin K, Thakrar H, White A. Luskin K, et al. Immunol Allergy Clin North Am. 2020 May;40(2):329-343. doi: 10.1016/j.iac.2019.12.002. Epub 2020 Jan 27. Immunol Allergy Clin North Am. 2020. PMID: 32278455 Review.
Aspirin-exacerbated respiratory disease (AERD) is characterized by eosinophilic chronic rhinosinusitis with nasal polyps, asthma, and upper-/lower-respiratory tract reactions to nonsteroidal antiinflammatory drugs. Persistent, severe disease, anosmia, and alcohol sensitivi …
Aspirin-exacerbated respiratory disease (AERD) is characterized by eosinophilic chronic rhinosinusitis with nasal polyps, asthma, and upper- …
Olfactory Function and Olfactory Disorders.
Hummel T, Power Guerra N, Gunder N, Hähner A, Menzel S. Hummel T, et al. Laryngorhinootologie. 2023 May;102(S 01):S67-S92. doi: 10.1055/a-1957-3267. Epub 2023 May 2. Laryngorhinootologie. 2023. PMID: 37130532 Free PMC article.
The sense of smell warns us of danger, and it allows us to perceive flavors when eating and drinking. In essence, this means quality of life. Therefore, anosmia must be taken seriously. Although olfactory receptor neurons are characterized by regenerative capacity, anos …
The sense of smell warns us of danger, and it allows us to perceive flavors when eating and drinking. In essence, this means quality of life …
"Anosmia" the mysterious collateral damage of COVID-19.
Ahmed AK, Sayad R, Mahmoud IA, El-Monem AMA, Badry SH, Ibrahim IH, Hafez MH, El-Mokhtar MA, Sayed IM. Ahmed AK, et al. J Neurovirol. 2022 Apr;28(2):189-200. doi: 10.1007/s13365-022-01060-9. Epub 2022 Mar 5. J Neurovirol. 2022. PMID: 35249186 Free PMC article. Review.
Anosmia is often the first and sometimes the only sign in the asymptomatic carriers of COVID-19. ...In this review, we highlighted the possible mechanisms of anosmia in COVID-19 patients, major pathologies and features of anosmia, implications of anosmia …
Anosmia is often the first and sometimes the only sign in the asymptomatic carriers of COVID-19. ...In this review, we highlighted th …
Male reproductive health in cystic fibrosis.
Yoon JC, Casella JL, Litvin M, Dobs AS. Yoon JC, et al. J Cyst Fibros. 2019 Oct;18 Suppl 2:S105-S110. doi: 10.1016/j.jcf.2019.08.007. J Cyst Fibros. 2019. PMID: 31679721 Free article. Review.
2,014 results